Fundraising FoxAptinyx
Evanston, US · Founded 2015 · Delaware corporation · 10 known investors
Find your way into Aptinyx
Sign up to see every warm intro you have to Aptinyx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aptinyx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Aptinyx was founded in 2015 by Joseph R. Moskal.
Board
Investors · 10
How we know: Bain Capital Life Sciences's portfolio page · board seat on SEC Form D · funding news · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · board seat on SEC Form D · Not right? Tell us
How we know: Latterell Venture Partners's portfolio page · Not right? Tell us
How we know: Longitude Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: OUP (Osage University Partners)'s portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: baincapital.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$95M disclosed across 2 rounds · 2016–2017
▶$70MraisedDec 2017 · 63 investors · PharmaceuticalsRule 506(b)
- Joseph R. MoskalExecutive Officer
- Terry P. GouldDirector
- Andrew D. KiddExecutive Officer
- James TopperDirector
- Ashish KhannaExecutive Officer
- Torsten M. MadsenExecutive Officer
- Liam RatcliffeDirector
- Adam M. KoppelDirector
- Wilbur H. Gantz IIIDirector
- Norbert G. RiedelExecutive Officer, Director
- Patrick EnrightDirector
- Offering amount
- $70M
- Amount sold
- $70M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$25MraisedMay 2016 · 48 investors · PharmaceuticalsRule 506(b)
- Joseph R. MoskalExecutive Officer
- Torsten M. MadsenExecutive Officer
- Liam RatcliffeDirector
- Ashish KhannaExecutive Officer
- Terry P. GouldDirector
- Wilbur H. Gantz IIIDirector
- James N. TopperDirector
- Patrick G. EnrightDirector
- Norbert G. RiedelExecutive Officer, Director
- Offering amount
- $65M
- Amount sold
- $25M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $2.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $311.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded Aptinyx?
- Aptinyx was founded by Joseph R. Moskal in 2015.
- Who are Aptinyx's investors?
- Aptinyx's investors include Bain Capital Life Sciences, Frazier Life Sciences, Latterell Venture Partners, Longitude Capital, OUP (Osage University Partners), Agent Capital, Bain Capital, HBM Healthcare Investments and 2 more.
- How much funding has Aptinyx raised?
- Aptinyx has disclosed $95M raised across 2 rounds.
- Where is Aptinyx headquartered?
- Aptinyx is headquartered in Evanston, US.